LY7-17046-85563
3 vaccinations
1 coded response
41 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 100 / NY
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Registered in v-safe
-
2021-03-09
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-09
Health check-in — day 0, dose 1Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-06-08
- 2021-09-07
-
2021-11-13
Dose 2 — Moderna
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-27
- 2021-12-06
- 2021-12-11
-
2021-12-18
Survey response — day 35, dose 2MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2021-12-25
- 2022-02-14
- 2022-05-14
-
2022-10-09
Dose 3 — Moderna
-
2022-10-09
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-10-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-23
- 2022-11-01
- 2022-11-06
- 2022-11-13
- 2022-11-20
- 2023-01-10
- 2023-04-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-13 | Moderna | No |
| 3 | 2022-10-09 | Moderna | No |
Free text
Release 10 — day 35, dose 2
Symptoms: Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release